Executive Briefing Series Subscription


Executive Briefing Series from FDAnews is designed for busy executives who have to stay up to date on multiple, complicated issues. Executive Briefing Series brings together tested and practical advice and information from experts around the world.

FDAnews’ staff finds the right expert on the right topic and culls their knowledge to bring you on-point summaries every month. Executive Briefing Series readers call it “invaluable” and “unique” and praise it for its timely and thorough coverage of key topics.

Last year alone subscribers to the Executive Briefing Series, received fully vetted articles on:

  • Principles of an Effective CAPA System: A Guide for Device and Drug Companies;
  • Responding to FDA 483s: Strategies for Successfully Obtaining Closeout;
  • FDA Drug Enforcement: An Analysis of Warning Letter Trends;
  • Managing Contract Manufacturers and Testing Labs;
  • Crafting Pharma Supplier Quality Agreements;
  • Documenting Process Validation: A Drugmaker’s Guide; and
  • Social Media Strategies for Drug and Device Companies.

There’s absolutely no risk to you. You get our 100% Money-Back Guarantee: If at any time, for any reason, you become dissatisfied with Executive Briefing Series , you may cancel your subscription and receive a full refund. No questions asked.

Don’t delay! There has never been a more important time — or a better opportunity — to take advantage of the timely, actionable information that Executive Briefing Series subscribers have benefited from for years.